Correction: Investigation of the impact of brewing parameters on toxic element and rare earth element contamination in oolong tea. [PDF]
Wu S +11 more
europepmc +1 more source
Second‐Order Between‐Supplier Learning
ABSTRACT Substantial empirical evidence shows that suppliers in emerging economies can enhance their technological capabilities through direct learning from technologically advanced foreign competitors. However, suppliers in emerging markets may struggle to learn directly from knowledge about competitors’ products that are not widely available on the ...
Lisha Liu, Xianwei Shi, Guangzhi Shang
wiley +1 more source
Understanding biopharmaceutical investment decision-making: how does Congressional Budget Office's model compare to investor insights? [PDF]
Hofer MP +4 more
europepmc +1 more source
ABSTRACT This study examines the extent to which intellectual capital (IC) supports firms' value generation and financial resilience, and how these effects are conditioned by profitability. IC is quantified using the “modified value‐added intellectual coefficient (MVAIC)” for a panel of 103 manufacturing firms listed on the Pakistan Stock Exchange over
Muhammad Danial +4 more
wiley +1 more source
A cost-benefit analysis of adult immunization programs across ten countries: Modeling the socioeconomic value of immunization for older populations compared to no vaccination. [PDF]
Chowdhury S +5 more
europepmc +1 more source
Nano Delivery Strategy Opens Effective Avenues for the Treatment of Colorectal Cancer
ABSTRACT Colorectal cancer (CRC) presents significant therapeutic challenges because of chemoresistance, systemic toxicity, and the complexity of the tumor microenvironment (TME). Nanodrug delivery systems (NDDS) have emerged as versatile platforms capable of overcoming these limitations by enhancing tumor accumulation, improving pharmacokinetics, and ...
Qiurong Wei +7 more
wiley +1 more source
The Rise of Health Economics: Transforming the Landscape of Economic Research. [PDF]
Gschwent L +3 more
europepmc +1 more source
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma +14 more
wiley +1 more source
Access in all areas? A round-up of developments in market access and health technology assessment: part 12. [PDF]
Ramagopalan SV, Pannelay AJ.
europepmc +1 more source

